All News

A recent report projects an 11% to 13% increase in total drug expenditures in hospitals and health systems in 2016.

Managing the costs of specialty pharmaceuticals is a perpetual task for specialty pharmacists.

The Centers for Medicare and Medicaid Services (CMS) has once again released its Physician Fee Schedule Proposed Rule for Calendar Year 2017.

Many smaller organizations rely on the 340B program to continue serving their communities – and they can’t afford penalties for noncompliance.

Daclizumab is the first subcutaneous injectable monoclonal antibody to be approved for the treatment of MS.

If you’re a pharmacist, you’ve undoubtedly heard the question, Are there too many pharmacy schools?

Somewhere in the United States, there may be a retail or specialty pharmacy that is not part of a group purchasing organization (GPO). If there is such a pharmacy, it is very hard to find.

The furor over EpiPen pricing is simply the best publicized of many similar price hikes that have left patients unable to pay.

Trying to enhance medication management across a continuum of care in a multi-facility hospital IT environment is no easy task.

The retail chain has linked itself with EnvisionRx.

While FDA recently approved two new biosimilars for rheumatoid arthritis and other inflammatory diseases, questions remain about how quickly physicians and patients will embrace the new drugs.

Generic drugmakers and others are pushing for faster FDA approval of generics.

The profitability of both chain and independent pharmacies is being affected by direct and indirect remuneration fees that insurers are retroactively charging pharmacies after filling Medicare Part D prescriptions.

In patients with COPD who have a history of exacerbations, a once-daily treatment regimen of combined fluticasone furoate and vilanterol was associated with fewer exacerbations than usual care without a greater risk of serious adverse events

Patients with severe COPD are likely to suffer frequent disease exacerbations and a reduced quality of life.

Already, HHS has awarded around $433 million for Zika response and preparedness activities. In addition, the new Senate and House budget, passed in late September, contained $1.1 billion in Zika funding.

The number of pharmacists providing vaccinations – both in the U.S. and around the world – is growing significantly.

Some customers are upset over CVS Pharmacy’s switch to different pill bottles than the ones Target has used for more than a decade.

A project that began a few years ago has resulted in a new, nationwide directory of pharmacies.

Santa Cruz, Calif. has become the first U.S. city to require retail pharmacies and drug manufacturers collect and dispose of unwanted prescription drugs.

Select Walgreens, Rite Aid, and other chain drugstores were among those cited by the FDA for selling e-cigarettes, e-liquid, and cigars to minors.

The agreement between CVS and Massachusetts requiring the PMP check prior to dispensing opioids is believed to be the first in the nation.

According to a recent report from the Institute of Safe Medication practices (ISMP), FDA received 34,765 adverse drug event reports for oral anticoagulants in 2015.

New Mexico's state motto is “The Land of Enchantment,” but it might also be dubbed the The Land of Opportunity. Pharmacists here are increasingly breaking barriers to deliver frontline, provider care services in an environment that fosters innovations for the profession, students, and patients.

These pharmacists forged their own paths.

Completion of Phase I of ASHP’s Standardize 4 Safety initiative is fast approaching.

When Express Scripts and CVS Health announced their 2017 formularies on August 1, a common theme emerged among the healthcare giants: several blockbuster drugs will be removed from both companies’ formularies and lower-cost options such as biosimilars are being embraced.

FDA approved Onzetra Xsail (Avanir Pharmaceuticals Inc.)- a fast-acting, low-dose sumatriptan dry powder formulation for the acute treatment of migraine with or without aura in adults.

Americans spend billions of dollars on products to address specific hair and scalp concerns each year-whether that be color, condition, or appearance.

Community pharmacists are caught in the middle of a battle between patients and their health insurers over how the federal government defines medical foods and how patients are paying for them.